Legal status | |
---|---|
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H27FN2O |
Molar mass | 330.447 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is the indazole analogue of XLR-11.
Legal status
Sweden's public health agency suggested classifying FAB-144 as a hazardous substance on November 10, 2014.
See also
References
- "FAB-144". Cayman Chemical. Retrieved 23 July 2015.
- "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.
This cannabinoid related article is a stub. You can help Misplaced Pages by expanding it. |